The Journal of Urology
Volume 174, Issue 1 , Pages 14-20, July 2005

UPDATE ON CHEMOTHERAPY FOR ADVANCED BLADDER CANCER

  • JONATHAN E. ROSENBERG

      Affiliations

    • Corresponding Author InformationDivision of Hematology/Oncology, Department of Medicine, University of California-San Francisco, 1600 Divisadero St., Box 1711, San Francisco, California 94115 (telephone: 415-353-7095; FAX: 415-353-7779).
    • Financial interest and/or other relationship with Praecis Pharmaceuticals.
    • ,
  • PETER R. CARROLL

      Affiliations

    • Financial interest and/or other relationship with TAP Pharmaceuticals, National Institutes of Health, AstraZeneca and Imatrimus.
    • ,
  • ERIC J. SMALL

From the Departments of Medicine (Division of Hematology/Oncology) and Urology (PC), University of California-San Francisco, San Francisco, California

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 30.00 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 Submitted for publication October 20, 2004.

PII: S0022-5347(05)60009-2

doi:10.1097/01.ju.0000162039.38023.5f

The Journal of Urology
Volume 174, Issue 1 , Pages 14-20, July 2005

Article Tools

* Image Usage & Resolution